Sign In
Sign Up
Two Blokes
US FDA approves expanded use of Moderna's RSV vaccine for at-risk adults
click to rate
Posted by
Two Blokes
Jun 13
- Filed in
Stock
- 5 views
The U.S. Food and Drug Administration on Thursday expanded the use of Moderna's respiratory syncytial virus vaccine to a lower group of high-risk adults aged 18 to 59 years.